| 1. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 2. | | Recruiting | Adenoidectomy for Otitis media in 2-3 Year Old Children
Condition: Otitis Media with Effusion |
| 3. | | Recruiting | Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
| 4. | | Not yet recruiting | Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 5. | | Recruiting | Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer |
| 6. | | Recruiting | Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
Conditions: Nasopharyngeal Cancer; Epstein-Barr Virus Infections |
| 7. | | Recruiting | Benzydamine in Treating Radiation-Induced Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, and/or Nasopharynx
Conditions: lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer |
| 8. | | Recruiting | Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 9. | | Recruiting | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: Head and Neck Cancer |
| 10. | | Recruiting | Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Conditions: Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; metastatic cancer |
| 11. | | Recruiting | Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Conditions: Chorea; Drug Induced Dyskinesia; Movement Disorder; Muscular Disease; Tic Disorder |
| 12. | | Recruiting | Brain Mapping of Voice Control
Condition: Voice Disorders |
| 13. | | Recruiting | Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer |
| 14. | | Recruiting | Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Condition: Head and Neck Cancer |
| 15. | | Recruiting | Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer; thorax and respiratory cancer |
| 16. | | Recruiting | Central Mechanisms in Speech Motor Control Studied with H215O PET
Conditions: Communication Disorder; Healthy; Stuttering; Tourette Syndrome; Voice Disorder |
| 17. | | Not yet recruiting | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 18. | | Recruiting | Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Nasopharyngeal Cancer; ... |
| 19. | | Recruiting | Characteristics of Idiopathic Familial Voice Disorders
Conditions: Laryngeal Disease; Spastic Dysphonia; Voice Disorder |
| 20. | | Recruiting | Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
| 21. | | Recruiting | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Condition: Cancer |
| 22. | | Recruiting | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer
Conditions: adult brain tumor; paranasal sinus and nasal cavity cancer; primary central nervous system lymphoma |
| 23. | | Recruiting | Chemotherapy With or Without Gene Therapy in Treating Patients With Unresectable Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 24. | | Recruiting | Clinical and Genetic Analysis of Inner Ear Malformations
Conditions: Sensorineural Hearing Loss; Cytomegalovirus Infection |
| 25. | | Recruiting | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Conditions: bone marrow ablation; Cancer |
| 26. | | Recruiting | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Conditions: Nose Cancers; Oral Cancer; Throat Cancer |
| 27. | | Recruiting | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Condition: Cancer |
| 28. | | Recruiting | Comparison of Gene Therapy With Chemotherapy in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer |
| 29. | | Recruiting | Cytochlor and Tetrahydrouridine as Radiosensitizers Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)
Conditions: stage III squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the oropharynx; ... |
| 30. | | Recruiting | Dextromethorphan to Treat Patients with Voice Spasms
Condition: Voice Disorders |
| 31. | | Recruiting | Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 32. | | Recruiting | Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss
Condition: Hearing Loss |
| 33. | | Recruiting | EBV-Specific CTLs Following CD45 Antibody to Patients with Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
Conditions: Nasopharyngeal Cancer; EBV Infections |
| 34. | | Recruiting | EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer
Condition: Head and Neck Cancer |
| 35. | | Recruiting | Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients
Condition: Laryngeal Cancer |
| 36. | | Recruiting | Electrical Muscle Stimulation to Aid Swallowing in Dysphagia
Conditions: Deglutition Disorder; Healthy |
| 37. | | Recruiting | Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans
Conditions: Diabetes; Tinnitus; Hearing Loss |
| 38. | | Recruiting | Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 39. | | Recruiting | Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
Conditions: stage II squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the oropharynx; ... |
| 40. | | Recruiting | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck
Conditions: Drug Toxicity; female reproductive cancer; Head and Neck Cancer; thorax and respiratory cancer |
| 41. | | Recruiting | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Condition: Cancer |
| 42. | | Recruiting | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 43. | | Recruiting | Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer |
| 44. | | Recruiting | Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Mesothelioma, Renal Cell Carcinoma (Kidney Cancer), Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cancer, or Invasive Breast Cancer
Conditions: Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; thorax and respiratory cancer |
| 45. | | Recruiting | Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Condition: neurofibromatosis 1 and 2 (NF1 and NF2) |
| 46. | | Recruiting | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
Conditions: stage II lymphoepithelioma of the nasopharynx; stage III lymphoepithelioma of the nasopharynx; stage IV lymphoepithelioma of the nasopharynx; ... |
| 47. | | Recruiting | Fruit and Vegetable Extracts in Treating Patients With Stage I, Stage II, Stage III, or Stage IVa Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
| 48. | | Recruiting | Functioning, Disability, and Quality of Life in the Adult Hearing Impaired
Condition: Hearing impaired |
| 49. | | Recruiting | Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
| 50. | | Recruiting | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer; thorax and respiratory cancer |
